NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines.

Mueller-Enz, Magdalena; Woopen, Christina; Katoul Al Rahbani, Georges; Haase, Rocco; Dunsche, Marie; Ziemssen, Tjalf; Akgün, Katja

Mueller-Enz, Magdalena; Woopen, Christina; Katoul Al Rahbani, Georges; Haase, Rocco; Dunsche, Marie; Ziemssen, Tjalf; Akgün, Katja.

Afiliação

Mueller-Enz M; Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Woopen C; Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Katoul Al Rahbani G; Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Haase R; Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Dunsche M; Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Ziemssen T; Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.
Akgün K; Center of Clinical Neuroscience, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany.

Front Immunol ; 14: 1081933, 2023.

Article em En | MEDLINE | ID: mdl-37545513

Assuntos

COVID-19; Esclerose Múltipla; Vacinas Virais; Humanos; Adulto; Pessoa de Meia-Idade; Vacinas contra COVID-19; Ad26COVS1; Vacina BNT162; ChAdOx1 nCoV-19; Estudos Longitudinais; Esclerose Múltipla/tratamento farmacológico; Estudos Prospectivos; COVID-19/prevenção & controle; SARS-CoV-2; Imunoglobulina G; Anticorpos Antivirais; Imunidade Celular

Palavras-chave

NVX-CoV2373; SARS-CoV-2 vaccination; anti-CD20 therapy; humoral and T cellular vaccination response; immunomodulation; multiple sclerosis; sphingosine-1phosphate receptor modulators

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas Virais / COVID-19 / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google